Many plant-derived natural products have been used in traditional medicine for the treatment of various diseases. Herba Epimedii is a traditional herbal medicine that has been reported as an effective enhancer of bone healing, [1] and it has been stated that its extracts can reduce the occurrence of ÖZ Amaç: Bu çalışmada femur kırıklı sıçan modelinde lokal olarak uygulanan ikariinin kemik kırığı iyileşmesi üzerine etkileri değerlendirildi. Gereç ve yöntemler: Çalışmaya sekiz ana çalışma grubunda 64 erkek Sprague-Dawley sıçan (ort. yaş 6 ay; ağırlık, 280-490 g) dahil edildi. Bir ekzojen osteo-indüktif madde olan ikariinin lokal olarak değişen dozlarda uygulanmasının kırık üzerine etkilerini araştırmak için kırık iyileşme süreci ve düzeyi radyografi, histopatoloji ve çift enerjili X-ışını absorbsiyometrisi ile değerlendirildi. İkariinin oksidanantioksidan sistemler üzerindeki etkilerini araştırmak için glutatyon (GSH) ve miyeloperoksidaz (MPO) düzeylerine ek olarak periferal kanda süperoksit dismutaz (SOD) ve glutatyon peroksidaz (GPx) aktiviteleri ölçüldü. Bulgular: Radyolojik kemik mineral yoğunluğu ölçümleri ve histopatolojik bulgular, ikariinin test edilen iki iyileşme döneminde tüm bu parametreleri geliştirdiğini ortaya koydu. Süperoksit dismutaz aktivitesi kırıklı tarafa lokal ikariin uygulaması ile birlikte azalırken, GPx ve GSH arttı ve MPO değişmedi. Ikariin, hidroksil radikali ve hidrojen peroksiti süpürmekten sorumlu olan GPx ve GSH düzeylerini artırdı. Sonuç: Lokal olarak kırık üzerine uygulanan ikariin oksidatif stresi azaltarak kemik iyileşmesini hızlandırdı.
osteoporosis not only in experimental studies but also in clinical studies. [2] It is known to increase the overall mineral content and therefore to promote bone formation and to increase lumbar bone mineral density (BMD). [3] In addition, the flavonoids of Herba Epimedii have been shown to concurrently improve osteogenic differentiation and inhibit the osteoclastic differentiation of human bone marrow-derived cells. [4] It is suggested that Epimedium-derived flavonoids including icariin have an anabolic effect on osteoporotic bone by concomitantly promoting the osteogenic differentiation of bone marrow stromal cells [5, 6] while suppressing adipogenic differentiation. [7] Fracture healing and bone repair which may result in unfavorable extension involve a combination of a series of complicated processes. [8] Oxidative stress, which is a cause of excessive production of free radicals, contributes to many different pathological conditions, including ischemia/perfusion, vasculogenesis and so on. [9] In order to stabilize the oxidation-reduction equilibration of free radicals in living organisms, first the removal of the radicals is achieved through enzymatic, i.e., first natural defense superoxide dismutase (SOD), myeloperoxidase (MPO), and glutathione (GSH), and nonenzymatic reactions. [10] At the promotion stage of fracture healing, a putative multiple-strategy approach involving local and cell-based systemic therapies that manipulate the morphogenetic processes is used to promote healing. [8] In this study, we aimed to evaluate the effects of locally applied icariin on bone fracture healing in femur fractured rat model.
MATERIALS AND METHODS
This study was conducted at Erciyes University, Experimental Research and Application Centre between 01 September 2013 and 30 October 2013. Sixty-four male Sprague Dawley rats (mean age 6 months; weighing, 280-490 g) were used in the study that were kept in individual cages at a constant temperature of 23±2°C with a 14/10 hours' light-dark cycle and fed standard pellet food and tap water. All procedures were performed in the Experimental Animals Breeding and Research Center of the Medical Faculty of Erciyes University, Kayseri, Turkey. Animal care was carried out with the prior approval of the Erciyes University Animal Experimental Ethics Committee on 10 April 2013 with approval number 13/63 and was in full compliance with Turkish Law 6343/2, Veterinary Medicine Deontology Regulation 6.7.26, and the Helsinki Declaration of Animal Rights.
The right femurs of all rats were fractured under intra peritoneal 3 mg/kg xylazine hydrochloride and ketamine hydrochloride general anesthesia. A Ruijin TM mini micro bone oscillating sagittal saw (Wuhu Ruijin Medical Instrument and Device Co., Ltd, Anhui, China) was used to create standard fractures as similar to each other as possible. Retrograde fixation was carried out using 1.5-mm Kirschner wires. The rats were randomly allocated to eight groups each consisting of eight rats: two control groups (control-3w and control-6w) and six study groups (icariin-3w2.5 mg, icariin-3w10 mg, icariin-3w25 mg, icariin-6w2.5 mg, icariin-6w10 mg, and icariin-6w25 mg). The control groups did not receive any additional treatment after surgical intervention. In the study groups, icariin was applied to the fracture locally once just after the fracture was created with the bone oscillating saw at dosages of 2.5, 10, or 25 mg. Icariin-3w2.5 mg, icariin-3w10 mg, icariin-3w25 mg, and control-3w groups were sacrificed three weeks and the remaining groups were sacrificed six weeks after the surgical intervention. Before the animals were sacrificed, anteroposterior and lateral radiographies of the femur were obtained, whole body BMD was measured, and 3 mL of blood was withdrawn for antioxidant analysis. After the rats were sacrificed, their entire right femurs were obtained and kept in 10% formaldehyde solution.
A previously described five-point scoring system modified by Warden et al. [11] was used to evaluate fracture healing: 0 points: no evidence of healing; 1 point: callus formation evident but fracture gap not bridged; 2 points: callus formation evident with bridging of the fracture gap but fracture line evident; 3 points: callus formation evident with bridging of the fracture gap with only faint fracture line; 4 points: fracture union. The radiological evaluation of each femur was performed in a double-blind manner by an orthopedist and a radiologist with no connection to the study. The mean of these fracture healing scores was used for analysis.
Dual-energy X-ray absorptiometry with a Hologic QDR 4500 ELITE Acclaim Series (Hologic, Massachusetts, USA) was used to measure the BMD of the femurs. High resolution measurements of area, bone mineral content, and BMD data were obtained from a region of interest approximately 1.6 (length)×1.28 (width) cm over the region of osteotomy in the left limb as well as the osteotomy-equivalent site in the right intact limb.
A 10-point scale was used for the histological evaluation of fracture healing: [12] 1 point: only fibrous; 2 points: predominantly fibrous tissue; 3 points: equal amounts of fibrous and cartilage tissue; 4 points: predominantly cartilage tissue with little fibrous tissue; 5 points: only cartilage tissue; 6 points: predominantly cartilage tissue with little immature bone tissue; 7 points: equal amounts of cartilage and immature bone tissue; 8 points: predominantly immature bone tissue with little cartilage tissue; 9 points: healing with immature bone tissue; 10 points: healing with mature bone tissue. The histopathological evaluation of each femur was conducted in a doubleblind manner by a pathologist with no connection to the study. Superoxide dismutase, GSH, GPx, and MPO levels were measured in the plasma. Blood samples for biochemical tests were taken from the right femoral vein of the rats. To obtain standard values of each biochemical parameter, eight rats in which fractures had been created in their femurs and physiological saline was applied locally were sacrificed at three weeks and eight more at six weeks. After separation of plasma, the samples were stored at -20°C until analysis. Spectrophotometric analyses were performed with a Biotec Synergy Multifunctional Microplate Reader using SOD (Biovision's SOD assay, Biovision Inc., Milpitas, CA, USA), total GSH (Cayman's GSH assay, Cayman Chemical Company, Ann Arbor, MI, USA), GPx (Biovision's GPx assay, Biovision Inc., Milpitas, CA, USA), and MPO (Cayman's MPO assay, Cayman Chemical Company, Ann Arbor, MI, USA) commercial kits according to the kit procedure.
Statistical analysis
The Shapiro-Wilk test and graphical methods were used to test the normality of the data. Intergroup comparisons of normally distributed continuous variables were performed using one-way analysis of variance. The Tukey honestly significant difference test or Dunnett's T3 test was used for pairwise comparisons depending on the homogeneity of variances. For the intergroup comparisons of variables without normal distribution, the Kruskal-Wallis test was used, and the Bonferroni corrected Mann- Whitney U test was used for pairwise comparisons. P value <0.05 was considered statistically significant.
RESULTS
Bone mineral density was higher among rats in which icariin had been locally applied compared with their control groups at both three and six weeks (Table I) . There was no significant difference between the three and six week groups. The highest BMD was in the icariin-6w25 mg group (p<0.05).
Similarly, radiological evaluation scores (Table II) were higher in the groups in which icariin had been locally applied compared with the controls at both three and six weeks (p<0.05). The icariin-3w25 mg group had the highest radiological score at three weeks among both the control and study groups (Figure 1 ). On the other hand, the icariin-6w10 mg group had the highest score overall (p<0.001) ( Figure I ).
Histopathological assessment scores were better at six weeks in the groups in which 10 and 25 mg of icariin had been locally applied, whereas the difference was not statistically significant at three weeks (Figure 2a, b) . Additionally, the BMD and histopathological assessment scores showed a dosedependent improvement between the two time points among the rats given icariin.
The plasma levels of the antioxidants SOD, GSH, and GPx are shown in Figures 3, 4 , and 5, respectively. Plasma SOD activity was decreased approximately 50% among the groups in which icariin had been locally applied compared with the controls at both three and six weeks. The lowest SOD activity (42%) was determined in the icariin-6w25 mg group (p<0.05). Glutathione values were highest in the icariin-3w10 mg and icariin-3w25 mg groups compared to the controls at both three and six weeks and compared to the icariin-6w2.5 mg, icariin-6w10 mg, and icariin-6w25 mg groups (p<0.05). According to these results, icariin increased the activity of GPx enzyme. The highest amount of GPx activity was at six weeks (2.5 mg) while the lowest was at three weeks (10 mg) in the study group. When these results were evaluated with the amount of GSH in the three week study group, which had the lowest GSH amount, the GPX had the lowest enzyme activity; on the other hand, in the six week study group, which had the lowest GSH, GPx had the highest enzyme activity. At three weeks, while the amount of GSH was high, GPx enzyme activity was low; the high radical scavenging effect of icariin was indicated at this week. At six weeks, icariin may cause an increase in the amount of GPx by increasing the expression of GPx enzyme. There was no significant difference in MPO activity within the groups (p>0.05).
DISCUSSION
The present study revealed the favorable effects of icariin in bone fracture, a condition associated with oxidative stress, in terms of both better healing and alterations in endogenous antioxidant levels. To determine the effects of icariin on the fractured side, the BMD of the callus tissue and histopathologic views of the fracture healing stages are also investigated.
Icariin had time-and dose-dependent positive effects BMD which was shown by the present study within rat's metabolism experimentally. This effect was supported and proved by Cao et al. [13] that icariin inhibits osteoporosis in vitro, potentially owing to its role in increasing bone morphogenetic protein-2 (BMP-2) expression, and that icariin promotes bone formation via the BMP-2/Smad4 signal transduction pathway in the human fetal osteoblastic 1.19 cell line. [14] In addition, the osteoblastic mechanism of icariin was demonstrated on MC3T3-E1 (osteoblast precursor cell line) cells and it was proved that icariin could facilitate MC3T3-E1 cells ingrowth and regulate osteoblastic differentiation. [15] Also, recent studies demonstrated that icariin stimulates The radiological evaluation scores were higher in the groups in which icariin had been locally administered. Those findings support the facilitation of bone formation by icariin via several mechanisms such as signal transduction effect, some bone formation related protein expression effect. [13, 14] Histopathological assessment scores were better as the time passed after the occurrence of fracture. In the present study, sixth week scores were higher in all groups regarding the controls. This should be related to the effect of icariin on osteoblasts and osteoclasts. This situation might be clarified by icariin's simulative effects on osteoblasts, inhibition of osteoclast differentiation [5, 6] and suppression of osteoclastogenesis. [7] Recent meta-analysis about in vivo studies of icariin indicates that icariin has a high osteo-inductive potential as a biomaterial for use in bone tissue engineering. According to this meta-analysis, icariin has several effects on the musculoskeletal system including anti-osteoporosis, osteogenesis, antiosteoclastogenesis, chondrogenesis, angiogenesis, and anti-inflammatory activities. [16] The effects of icariin on the oxidant-antioxidant system were evaluated in this study biochemically by measuring the activities of SOD and GPx as well as GSH and MPO levels in the peripheral blood. SOD activity decreased in association with local icariin application to the fractured side, whereas GPx and GSH increased and MPO remained unchanged. This alteration may be explained by the reduced need for endogenous antioxidant SOD scavenging superoxide dismutase (O2 • ) radical. Furthermore, icariin increased the GPx and GSH levels, which are responsible for scavenging hydroxyl radical (OH • ) and hydrogen peroxide (H 2 O 2 ). This effect might be due to the radicals formed in the environment during the activation period of the enzymes. The activation of first defense antioxidant mechanisms; GPx and GSH due to the formation of OH • radical and H 2 O 2 might reduce the amount of O2 • radical. The reduced O2 • radical causes less need for SOD activity; therefore, in the present study, SOD should be decreased. However, this should be further investigated molecularly to identify its mechanisms of action on these enzymes.
Furthermore, icariin was also shown to inhibit apoptosis and preserve viability by reducing the production of reactive oxygen species and malonyldialdehyde and increasing SOD activity. [17] Another study related to the in vitro antioxidant effects of icariin showed that significantly decreased amounts of 1, 1diphenyl-2-picryl hydrazyl, O2 • , and OH • radicals were detected when the cell culture medium was treated with icariin. [18] This study has some limitations such as biomechanical and molecular evaluation of the study and control groups unioned fractures. Another limitation is application type and dosage. The clinical effects of icariin; local or sistemic, optimum dosage for aplications should be investigated in detailed.
In conclusion, locally administered icariin to the fracture facilitates bone healing via improving antioxidant responses within the fracture site. Further bimolecular studies are required to highlight the underlying mechanism of these effects. In addition, the effects of icariin in clinical settings are warranted.
